|
|
||||||||
J Thorac Cardiovasc Surg 2007;133:632-639
© 2007 The American Association for Thoracic Surgery
Surgery for Congenital Heart Disease |
a Michael E. DeBakey Department of Surgery, Division of Congenital Heart Surgery, Baylor College of Medicine, Houston, Tex
b Division of Congenital Heart Surgery, Texas Childrens Hospital, Houston, Tex
c Division of Pediatric Cardiology, Department of Pediatrics, Baylor College of Medicine, Houston, Tex
d Texas Heart Institute at St Lukes Episcopal Hospital, Department of Thoracic and Cardiovascular Surgery, Houston, Tex.
Read at the Eighty-sixth Annual Meeting of The American Association for Thoracic Surgery, Philadelphia, Pa, April 29-May 3, 2006.
Received for publication April 29, 2006; revisions received August 25, 2006; accepted for publication September 25, 2006. * Address for reprints: David L.S. Morales, MD, Division of Congenital Heart Surgery, Texas Childrens Hospital, 6621 Fannin St, MC-WT 19345H, Houston, TX 77030. (Email: dlmorale{at}texaschildrenshospital.org).
Objective: In 1984, the first successful infant heart transplant was performed at Texas Childrens Hospital. This study analyzes the 21-year experience with pediatric heart transplantation at Texas Childrens Hospital to assess whether and how survival has changed over time.
Methods: Between November 1, 1984, and October 3, 2005, 164 consecutive orthotopic heart transplants were performed on 154 patients. Characteristics: mean age 7.1 ± 6.0 years, mean body surface area 0.8 ± 0.5 m2. Diagnosis at transplant: cardiomyopathy 53.0% (n = 87), congenital heart defect 39.0% (n = 64), retransplant 7.9% (n = 13). Multivariate risk factor analysis of 32 variables was completed by Cox proportional hazards regression models.
Results: Mean follow-up was 5.9 ± 4.8 years. Overall KaplanMeier survival was 82% at 1 year, 65% at 5 years, and 54% at 10 years. After 1995, KaplanMeier survival (91% at 1 year and 71% at 5 years) was significantly improved over pre-1995 survival (71% at 1 year, 57% at 5 years, and 48% at 10 years; P =.026). Hospital survival improved in the post-1995 era (96%) compared with the pre-1995 era (77%; P < .001). Life-table analysis by yearly increments demonstrates only an improved survival (pre-1995, 71%
post-1995, 91%) in the first posttransplant year (P = .001); every subsequent year the mortality rates are the same (P = .92). Risk factors for overall mortality are prolonged postoperative intubation (>5 days) and longer cardiopulmonary bypass time.
Conclusions: Primarily attributable to an increase in early survival, overall pediatric heart transplant survival is improved. However, after the first posttransplant year, the rate of mortality has not changed in 21 years. This highlights the need for new therapies to treat children both with or in need of a heart transplant.
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| ANN THORAC SURG | ASIAN CARDIOVASC THORAC ANN | EUR J CARDIOTHORAC SURG |
| J THORAC CARDIOVASC SURG | ICVTS | ALL CTSNet JOURNALS |